HD-OPM Archive
Topics › Insulin resistance & diabetes

Metformin eased knee osteoarthritis pain more than placebo in a 6-month Australian RCT

Louis Nervegna · Apr 25, 2025 · ♥ 3 reactions · 0 comments · original Facebook post
Insulin resistance & diabetesAging & longevity
AI summary & key facts

Luigi Fontana's summary of a JAMA RCT in people with knee osteoarthritis and overweight/obesity: metformin reduced pain more than placebo. He frames it as aging biology (AMPK, mTOR, inflammation) as a treatment target, and notes lifestyle approaches like caloric restriction act on the same pathways. Little direct heart relevance.

#metforminHD #arthritisHD #kneeHD

Research cited

Can a diabetes drug help ease knee pain in osteoarthritis?

A new randomized, placebo-controlled trial from Australia suggests metformin—best known for treating type 2 diabetes—may also reduce knee pain in people with osteoarthritis and overweight/obesity.

Paper · JAMAJAMA articlejamanetwork.com

Over 6 months, participants on metformin experienced a greater reduction in pain than those on placebo (−31.3 mm vs −18.9 mm on a 100-mm VAS). This supports the idea that targeting aging biology, rather than just symptoms, could be a promising strategy in managing chronic conditions like osteoarthritis.

But there's more to the story.

Metformin mimics some of the molecular effects of lifestyle interventions like caloric restriction (CR)—which target the same aging-related pathways (AMPK, mTOR, inflammation). Importantly, lifestyle-based approaches may offer even stronger and more comprehensive benefits for long-term health and functional aging.

Paper · Nat Rev Mol Cell Biol · 2022Molecular mechanisms of dietary restriction promoting health and longevity.Dietary restriction with adequate nutrition is the gold standard for delaying ageing and extending healthspan and lifespan in diverse species, including rodents and non-human primates. In this Review, we discuss the effects of dietary restriction in these mammalian model organisms and discuss accumulating data that suggest that dietary restriction results in many of the same physiological, metabolic and molecular…pmc.ncbi.nlm.nih.gov

The takeaway?
We’re entering an era where aging biology is a therapeutic target. Whether through drugs or lifestyle, modulating these pathways could transform how we treat age-related diseases.

Let’s build a future where people not only live longer—but move better, feel better, and stay independent longer.

#HealthyAging #Osteoarthritis #Metformin #CaloricRestriction #LongevityScience #TranslationalResearch #LifestyleMedicine #Geroscience

No photo description available.
← newer: Vitamin D lowered depression symptoms dose-dependently in meolder: No risk factors at 50 meant up to 13.3 more CVD-free years i →